Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 29, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Eric Joseph Upgraded (BEAM) to Buy and Increased Target to $40 on, Jan 29th, 2024
Eric Joseph of JP Morgan, Upgraded "Beam Therapeutics Inc." (BEAM) to Buy and Increased Target from $38 to $40 on, Jan 29th, 2024.
Eric has made no other calls on BEAM in the last 4 months.
There are 3 other peers that have a rating on BEAM. Out of the 3 peers that are also analyzing BEAM, 2 agree with Eric's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Greg Harrison of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $35 on, Friday, December 15th, 2023
- Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $30 on, Friday, December 8th, 2023
This is the rating of the analyst that currently disagrees with Eric
- Rick Bienkowski of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $32 on, Tuesday, October 17th, 2023
